Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia

Qin, Shukui; Bai, Yuxian; Yeong Lim, Ho; Thongprasert, Sumitra; Chao, Yee; Fan, Jia; Yang, Tsai‐Shen; Bhudhisawasdi, Vajarabhongsa; Ki Kang, Won; Zhou, Yu; Hyun Lee, Jee; Sun, Yan

doi:10.1200/jco.2012.44.5643

Public

Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia

Published in Journal of Clinical Oncology • Aug 27, 2013

Authors:

Shukui Qin

Yuxian Bai

Ho Yeong Lim

Abstract

PURPOSE: To determine whether FOLFOX4 (infusional fluorouracil, leucovorin, and oxaliplatin) administered as palliative chemotherapy to patients with advanced hepatocellular carcinoma (HCC) provides a survival benefit and efficacy versus doxorubicin. PATIENTS AND METHODS: This multicenter, open-labe...

Subject

Medicine

Oxaliplatin

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!